60 Although modest at the individual level, a 5 mm Hg SBP reduction has been associated with about a 10% lower risk of major cardiovascular events, including 13% reductions in both stroke and heart failure, 8% in ischemic heart disease, and 5% in cardiovascular death, making these effects important at a population level
10.1016/j.snb.2016.08.019 28 SyslovaK.RambousekL.KuzmaM.NajmanovaV.Bubenikova-ValesovaV.SlamberovaR.et al (2011)
Steinman J, Sun HS, Feng ZP
In this breakthrough, researchers cultivated stem cells that could transform into beta cells, the cells responsible for producing insulin
Depending on the individual medicine and its FDA-approved indication, GLP-1 receptor agonists may: Stimulate insulin release when blood glucose is elevated Reduce glucagon secretion Slow stomach emptying Increase feelings of fullness Support lower blood glucose Help some patients reduce body weight Semaglutide is a GLP-1 receptor agonist available in several prescription products